The NF-Y/p53 liaison: Well beyond repression
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
NF-Y is a sequence-specific transcription factor - TF - targeting the common CCAAT promoter element. p53 is a master TF controlling the response to stress signals endangering genome integrity, often mutated in human cancers. The NF-Y/p53 - and p63, p73 - interaction results in transcriptional repression of a subset of genes within the vast NF-Y regulome under DNA-damage conditions. Recent data shows that NF-Y is also involved in pro-apoptotic activities, either directly, by mediating p53 transcriptional activation, or indirectly, by being targeted by a non coding RNA, PANDA. The picture is subverted in cells carrying Gain-of-function mutant p53, through interactions with TopBP1, a protein also involved in DNA repair and replication. In summary, the connection between p53 and NF-Y is crucial in determining cell survival or death.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Large Intergenic Noncoding RNA Induced by p53 Mediates Global Gene Repression in the p53 Response
Huarte, M., Guttman, M., Feldser, D., Garber, M., Koziol, M. J., Kenzelmann-Broz, D., Khalil, A. M., Zuk, O., Amit, I., Rabani, M., et al. (2010) · Cell · doi:10.1016/j.cell.2010.06.040 · Cited by 2,053
Definition of a consensus binding site for p53
El-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W., & Vogelstein, B. (1992) · Nature Genetics · doi:10.1038/ng0492-45 · Cited by 1,985
Transcriptional control of human p53-regulated genes
Riley, T., Sontag, E., Chen, P., & Levine, A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2395 · Cited by 1,921
Haupt, S., Berger, M., Goldberg, Z., & Haupt, Y. (2003) · Journal of Cell Science · doi:10.1242/jcs.00739 · Cited by 1,136
When mutants gain new powers: News from the mutant p53 field
Brosh, R., & Rotter, V. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2693 · Cited by 1,132
An atlas of combinatorial transcriptional regulation in mouse and man
Ravasi, T., Suzuki, H., Cannistraci, C. V., Katayama, S., Bajic, V. B., Tan, K., Akalin, A., Schmeier, S., Kanamori-Katayama, M., Bertin, N., et al. (2010) · Cell · doi:10.1016/j.cell.2010.01.044 · Cited by 715
The expanding universe of p53 targets
Menendez, D., Inga, A., & Resnick, M. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2730 · Cited by 568
Gaiddon, C., Lokshin, M., Ahn, J., Zhang, T., & Prives, C. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.5.1874-1887.2001 · Cited by 464
Di Agostino, S., Strano, S., Emiliozzi, V., Zerbini, V., Mottolese, M., Sacchi, A., Blandino, G., & Piaggio, G. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.08.013 · Cited by 418
p63 and p73, the ancestors of p53
Dotsch, V., Bernassola, F., Coutandin, D., Candi, E., & Melino, G. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004887 · Cited by 326
Espinosa, J. M., Verdun, R. E., & Emerson, B. M. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00359-9 · Cited by 256
p21/CDKN1A Mediates Negative Regulation of Transcription by p53
Löhr, K., Möritz, C., Contente, A., & Dobbelstein, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212517200 · Cited by 227
Borellini, F., & Glazer, R. I. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53046-5 · Cited by 147
p53-dependent Down-regulation of Telomerase Is Mediated by p21
Shats, I., Milyavsky, M., Tang, X., Stambolsky, P., Erez, N., Brosh, R., Kogan, I., Braunstein, I., Tzukerman, M., Ginsberg, D., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402502200 · Cited by 133
The G2 Checkpoint Is Maintained by Redundant Pathways
Passalaris, T. M., Benanti, J. A., Gewin, L., Kiyono, T., & Galloway, D. A. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.9.5872 · Cited by 116
Regulation of the p53 transcriptional response by structurally diverse core promoters
Morachis, J. M., Murawsky, C. M., & Emerson, B. M. (2010) · Genes & Development · doi:10.1101/gad.1856710 · Cited by 86
Tabach, Y., Milyavsky, M., Shats, I., Brosh, R., Zuk, O., Yitzhaky, A., Mantovani, R., Domany, E., Rotter, V., & Pilpel, Y. (2005) · Molecular Systems Biology · doi:10.1038/msb4100030 · Cited by 72
Self-citationFunction of TopBP1 in Genome Stability
Sokka, M., Parkkinen, S., Pospiech, H., & Syväoja, J. E. (2010) · Subcellular Biochemistry · doi:10.1007/978-90-481-3471-7_7 · Cited by 38
Research works printed but not linked: 118
- Vousden, 2002, Activation of the p53 tumor suppressor protein, Biochim. Biophys. Acta, 1602, 47
- Dolfini, 2009, A perspective of promoter architecture from the CCAAT box, Cell Cycle, 8, 4127, 10.4161/cc.8.24.10240 · DOI
- Romier, 2003, The NF-YB/NF-YC structure gives insight into DNA binding and transcription regulation by CCAAT factor NF-Y, J. Biol. Chem., 278, 1336, 10.1074/jbc.M209635200 · DOI · Paper page
- Kamada, 2001, Crystal structure of negative cofactor 2 recognizing the TBP-DNA transcription complex, Cell, 106, 71, 10.1016/S0092-8674(01)00417-2 · DOI · Paper page
- Poot, 2000, HuCHRAC, a human ISWI chromatin remodelling complex contains hACF1 and two novel histone-fold proteins, EMBO J., 19, 3377, 10.1093/emboj/19.13.3377 · DOI · Paper page
- Li, 2000, Identification and cloning of two histone fold motif-containing subunits of HeLa DNA polymerase epsilon, J. Biol. Chem., 275, 23247, 10.1074/jbc.M002548200 · DOI · Paper page
- Bolognese, 2000, Cloning and characterization of the histone-fold proteins YBL1 and YCL1, Nucleic Acids Res., 28, 3830, 10.1093/nar/28.19.3830 · doi:10.1093/nar/28.19.3830
- Vousden, 2002, Live or let die: the cell's response to p53, Nat Rev Cancer, 2, 594, 10.1038/nrc864 · DOI · Paper page
- Funk, 1992, A transcriptionally active DNA-binding site for human p53 protein complexes, Mol. Cell. Biol., 12, 2866, 10.1128/MCB.12.6.2866 · DOI · Paper page
- Bourdon, 1997, Further characterisation of the p53 responsive element—identification of new candidate genes for trans-activation by p53, Oncogene, 14, 85, 10.1038/sj.onc.1200804 · DOI
- el-Deiry, 1998, Regulation of p53 downstream genes, Semin. Cancer Biol., 8, 345, 10.1006/scbi.1998.0097 · DOI · Paper page
- Ko, 1996, p53: puzzle and paradigm, Genes Dev., 10, 1054, 10.1101/gad.10.9.1054 · DOI · Paper page
- Willis, 2002, The promise and obstacle of p53 as a cancer therapeutic agent, Curr. Mol. Med., 2, 329, 10.2174/1566524023362474 · DOI
- Ceribelli, 2008, The histone-like NF-Y is a bifunctional transcription factor, Mol. Cell. Biol., 28, 2047, 10.1128/MCB.01861-07 · DOI
- Böhlig, 2011, One function—multiple mechanisms: the manifold activities of p53 as a transcriptional repressor, J. Biomed. Biotechnol., 2011, 464916, 10.1155/2011/464916 · DOI · Paper page
- Wang, 2010, The p53 response element and transcriptional repression, Cell Cycle, 9, 870, 10.4161/cc.9.5.10825 · DOI · Paper page
- Zhao, 2000, Analysis of p53-regulated gene expression patterns using oligonucleotide arrays, Genes Dev., 14, 981, 10.1101/gad.14.8.981 · DOI · Paper page
- Murphy, 1996, Wild-type p53 negatively regulates the expression of a microtubule-associated protein, Genes Dev., 10, 2971, 10.1101/gad.10.23.2971 · DOI · Paper page
- Tokino, 1994, p53 tagged sites from human genomic DNA, Hum. Mol. Genet., 3, 1537, 10.1093/hmg/3.9.1537 · DOI · Paper page
- Johnson, 2001, Transcriptional repression by p53 through direct binding to a novel DNA element, J. Biol. Chem., 276, 27716, 10.1074/jbc.C100121200 · DOI · Paper page
- Hoffman, 2002, Transcriptional repression of the anti-apoptotic survivin gene by wild type p53, J. Biol. Chem., 277, 3247, 10.1074/jbc.M106643200 · DOI · Paper page
- Wang, 2009, Redefining the p53 response element, Proc. Natl. Acad. Sci. U. S. A., 106, 14373, 10.1073/pnas.0903284106 · DOI · Paper page
- Wang, 2009, LIM and SH3 protein 1 (Lasp1) is a novel p53 transcriptional target involved in hepatocellular carcinoma, J. Hepatol., 50, 528, 10.1016/j.jhep.2008.10.025 · DOI
- D'Souza, 2001, The gene encoding p202, an interferon-inducible negative regulator of the p53 tumor suppressor, is a target of p53-mediated transcriptional repression, J. Biol. Chem., 276, 298, 10.1074/jbc.M007155200 · DOI
- Kho, 2004, p53-regulated transcriptional program associated with genotoxic stress-induced apoptosis, J. Biol. Chem., 279, 21183, 10.1074/jbc.M311912200 · DOI · Paper page
- Arias-Lopez, 2006, p53 modulates homologous recombination by transcriptional regulation of the RAD51 gene, EMBO Rep., 7, 219, 10.1038/sj.embor.7400587 · DOI · Paper page
- Hsieh, 2008, Human DDA3 is an oncoprotein down-regulated by p53 and DNA damage, Biochem. Biophys. Res. Commun., 369, 567, 10.1016/j.bbrc.2008.02.047 · DOI
- Zhang, 2004, Repression of hsp90beta gene by p53 in UV irradiation-induced apoptosis of Jurkat cells, J. Biol. Chem., 279, 42545, 10.1074/jbc.M314213200 · DOI · Paper page
- Li, 2004, Identification of PRC1 as the p53 target gene uncovers a novel function of p53 in the regulation of cytokinesis, Oncogene, 23, 9336, 10.1038/sj.onc.1208114 · DOI
- van Bodegom, 2010, Mechanisms of p53-mediated repression of the human polycystic kidney disease-1 promoter, Biochim. Biophys. Acta, 1799, 502, 10.1016/j.bbagrm.2010.04.001 · DOI
- Taylor, 2001, Regulation of the G2/M transition by p53, Oncogene, 20, 1803, 10.1038/sj.onc.1204252 · DOI · Paper page
- de Toledo, 1998, Regulation by ionizing radiation of CDC2, cyclin A, cyclin B, thymidine kinase, topoisomerase IIalpha, and RAD51 expression in normal human diploid fibroblasts is dependent on p53/p21Waf1, Cell Growth Differ, 9, 887
- Yun, 1999, p53 negatively regulates cdc2 transcription via the CCAATbinding NF-Y transcription factor, J. Biol. Chem., 274, 29677, 10.1074/jbc.274.42.29677 · DOI · Paper page
- Innocente, 1999, p53 regulates a G2 checkpoint through cyclin B1, Proc. Natl. Acad. Sci. U. S. A., 96, 2147, 10.1073/pnas.96.5.2147 · DOI · Paper page
- Taylor, 1999, Mechanisms of G2 arrest in response to overexpression of p53, Mol. Biol. Cell, 10, 3607, 10.1091/mbc.10.11.3607 · DOI · Paper page
- Krause, 2000, The tumour suppressor protein p53 can repress transcription of cyclin B, Nucleic Acids Res., 28, 4410, 10.1093/nar/28.22.4410 · DOI · Paper page
- Krause, 2001, Expression of the cell cycle phosphatase cdc25C is down-regulated by the tumour suppressor protein p53 but not by p73, Biochem. Biophys. Res. Commun., 284, 743, 10.1006/bbrc.2001.5040 · DOI
- Manni, 2001, NF-Y mediates the transcriptional inhibition of the cyclin B1, cyclin B2, and cdc25C promoters upon induced G2 arrest, J. Biol. Chem., 276, 5570, 10.1074/jbc.M006052200 · DOI · Paper page
- Badie, 2000, Repression of CDK1 and other genes with CDE and CHR promoter elements during DNA damage-induced G(2)/M arrest in human cells, Mol. Cell. Biol., 20, 2358, 10.1128/MCB.20.7.2358-2366.2000 · DOI · Paper page
- Zhu, 2002, Identification of promoter elements responsible for transcriptional inhibition of polo-like kinase 1 and topoisomerase IIalpha genes by p21(WAF1/CIP1/SDI1), Cell Cycle, 1, 59, 10.4161/cc.1.1.101 · DOI · Paper page
- St Clair, 2004, DNA damage-induced downregulation of Cdc25C is mediated by p53 via two independent mechanisms: one involves direct binding to the cdc25C promoter, Mol. Cell, 16, 725, 10.1016/j.molcel.2004.11.002 · DOI · Paper page
- Matsui, 2004, Negative regulation of Chk2 expression by p53 is dependent on the CCAAT-binding transcription factor NF-Y, J. Biol. Chem., 279, 25093, 10.1074/jbc.M403232200 · DOI · Paper page
- Imbriano, 2005, Direct p53 transcriptional repression: in vivo analysis of CCAAT-containing G2/M promoters, Mol. Cell. Biol., 25, 3737, 10.1128/MCB.25.9.3737-3751.2005 · DOI · Paper page
- Basile, 2006, DNA damage promotes histone deacetylase 4 nuclear localization and repression of G2/M promoters, via p53 C-terminal lysines, J. Biol. Chem., 281, 2347, 10.1074/jbc.M507712200 · DOI
- Scian, 2008, Wild-type p53 and p73 negatively regulate expression of proliferation related genes, Oncogene, 27, 2583, 10.1038/sj.onc.1210898 · DOI
- St Clair, 2006, The dual specificity phosphatase Cdc25C is a direct target for transcriptional repression by the tumor suppressor p53, Cell Cycle, 5, 709, 10.4161/cc.5.7.2628 · DOI
- Kaeser, 2002, Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivo, Proc. Natl. Acad. Sci. U. S. A., 99, 95, 10.1073/pnas.012283399 · DOI · Paper page
- Ceribelli, 2006, Repression of new p53 targets revealed by ChIP on chip experiments, Cell Cycle, 5, 1102, 10.4161/cc.5.10.2777 · DOI · Paper page
- Shaked, 2008, Chromatin immunoprecipitation-on-chip reveals stress-dependent p53 occupancy in primary normal cells but not in established cell lines, Cancer Res., 68, 9671, 10.1158/0008-5472.CAN-08-0865 · DOI · Paper page
- Elkon, 2003, Genome-wide in silico identification of transcriptional regulators controlling the cell cycle in human cells, Genome Res., 13, 773, 10.1101/gr.947203 · DOI · Paper page
- Linhart, 2005, Deciphering transcriptional regulatory elements that encode specific cell cycle phasing by comparative genomics analysis, Cell Cycle, 4, 1788, 10.4161/cc.4.12.2173 · DOI · Paper page
- Halperin, 2009, Allegro: analyzing expression and sequence in concert to discover regulatory programs, Nucleic Acids Res., 37, 1566, 10.1093/nar/gkn1064 · DOI
- McKenzie, 2010, p53-dependent repression of polo-like kinase-1, Cell Cycle, 15, 4200, 10.4161/cc.9.20.13532 · DOI · Paper page
- Banerjee, 2009, DNA damage induced p53 downregulates Cdc20 by direct binding to its promoter causing chromatin remodeling, Nucleic Acids Res., 37, 2688, 10.1093/nar/gkp110 · DOI · Paper page
- Yang, 2008, Kinetics of repression by modified p53 on the PDGF beta-receptor promoter, Int. J. Cancer, 123, 2020, 10.1002/ijc.23735 · DOI
- Yun, 2003, Cdk2-dependent phosphorylation of the NF-Y transcription factor and its involvement in the p53-p21 signaling pathway, J Biol Chem, 278, 36966, 10.1074/jbc.M305178200 · DOI · Paper page
- Chae, 2004, Cdk2-dependent phosphorylation of the NF-Y transcription factor is essential for the expression of the cell cycle-regulatory genes and cell cycle G1/S and G2/M transitions, Oncogene, 23, 4084, 10.1038/sj.onc.1207482 · DOI
- Yun, 2006, p53 prevents immature escaping from cell cycle G2 checkpoint arrest through inhibiting cdk2-dependent NF-Y phosphorylation, Cancer Res Treat, 38, 224, 10.4143/crt.2006.38.4.224 · DOI
- Jin, 1998, Transcriptional regulation of the MDR1 gene by histone acetyltransferase and deacetylase is mediated by NF-Y, Mol. Cell. Biol., 18, 4377, 10.1128/MCB.18.7.4377 · DOI · Paper page
- Peng, 2007, Irradiation modulates association of NF-Y with histone-modifying cofactors PCAF and HDAC, Oncogene, 26, 7576, 10.1038/sj.onc.1210565 · doi:10.1038/sj.onc.1210565
- Kato, 2009, Characterization of the HDAC1 complex that regulates the sensitivity of cancer cells to oxidative stress, Cancer Res., 69, 3597, 10.1158/0008-5472.CAN-08-4368 · DOI
- Rinn, 2011, To repress or not to repress: this is the guardian's question, Trends Cell Biol., 21, 344, 10.1016/j.tcb.2011.04.002 · DOI
- Godar, 2008, Growth-inhibitory and tumor-suppressive functions of p53 depend on its repression of CD44 expression, Cell, 134, 62, 10.1016/j.cell.2008.06.006 · DOI · Paper page
- Li, 1998, Xenopus NF-Y pre-sets chromatin to potentiate p300 and acetylation-responsive transcription from the Xenopus hsp70 promoter in vivo, EMBO J., 17, 6300, 10.1093/emboj/17.21.6300 · DOI · Paper page
- Wu, 2005, DeltaNp63alpha up-regulates the Hsp70 gene in human cancer, Cancer Res., 65, 758, 10.1158/0008-5472.758.65.3 · DOI
- Xu, 2001, Transcriptional activity of the SHP-1 gene in MCF7 cells is differentially regulated by binding of NF-Y factor to two distinct CCAAT-elements, Gene, 269, 141, 10.1016/S0378-1119(01)00445-0 · DOI
- Montano, 2009, Repression of SHP-1 expression by p53 leads to trkA tyrosine phosphorylation and suppression of breast cancer cell proliferation, Oncogene, 28, 3787, 10.1038/onc.2009.143 · DOI
- Clem, 2003, Characterization of the role of Sp1 and NF-Y in differential regulation of PTTG/securin expression in tumor cells, Gene, 322, 113, 10.1016/j.gene.2003.08.012 · doi:10.1016/j.gene.2003.08.012
- Gatta, 2008, NF-Y substitutes H2A-H2B on active cell-cycle promoters: recruitment of CoREST-KDM1 and fine-tuning of H3 methylations, Nucleic Acids Res., 36, 6592, 10.1093/nar/gkn699 · DOI
- Benlhabib, 2006, Expression of the Op18 gene is maintained by the CCAAT-binding transcription factor NF-Y, Gene, 377, 177, 10.1016/j.gene.2006.04.004 · doi:10.1016/j.gene.2006.04.004
- Fung, 2001, Key role of a downstream specificity protein 1 site in cell cycle-regulated transcription of the AP endonuclease gene APE1/APEX in NIH3T3 cells, J. Biol. Chem., 276, 42011, 10.1074/jbc.M106423200 · DOI
- Fan, 2002, BRCA1 regulates GADD45 through its interactions with the OCT-1 and CAAT motifs, J. Biol. Chem., 277, 8061, 10.1074/jbc.M110225200 · DOI
- Coustry, 2001, CBF/NF-Y functions both in nucleosomal disruption and transcription activation of the chromatin-assembled topoisomerase IIalpha promoter. Transcription activation by CBF/NF-Y in chromatin is dependent on the promoter structure, J. Biol. Chem., 276, 40621, 10.1074/jbc.M106918200 · DOI
- Pesce, 1999, Interaction between the (−170) CRE and the (−150) CCAAT box is necessaryfor efficient activation of the fibronectin gene promoter by cAMP and ATF-2, FEBS Lett., 457, 445, 10.1016/S0014-5793(99)01091-1 · DOI
- Alonso, 1996, The CCAAT-binding proteins CP1 and NF-I cooperate with ATF-2 in the transcription of the fibronectin gene, J. Biol. Chem., 271, 22271, 10.1074/jbc.271.36.22271 · DOI
- Ratovitski, 2010, LKB1/PEA3/ΔNp63 pathway regulates PTGS-2 (COX-2) transcription in lung cancer cells upon cigarette smoke exposure, Oxid. Med. Cell. Longev., 3, 317, 10.4161/oxim.3.5.13108 · DOI
- Faniello, 2008, p53-mediated downregulation of H ferritin promoter transcriptional efficiency via NF-Y, Int. J. Biochem. Cell Biol., 40, 2110, 10.1016/j.biocel.2008.02.010 · DOI · Paper page
- Zhou, 2003, DNA damage-induced inhibition of securin expression is mediated by p53, J. Biol. Chem., 278, 462, 10.1074/jbc.M203793200 · DOI
- Rother, 2007, p53 downregulates expression of the G(1)/S cell cycle phosphatase Cdc25A, Oncogene, 26, 1949, 10.1038/sj.onc.1209989 · DOI
- Rother, 2007, Gene expression of cyclin-dependent kinase subunit Cks2 is repressed by the tumor suppressor p53 but not by the related proteins p63 or p73, FEBS Lett., 581, 1166, 10.1016/j.febslet.2007.02.028 · DOI
- Rother, 2007, Expression of cyclin-dependent kinase subunit 1 (Cks1) is regulated during the cell cycle by a CDE/CHR tandem element and is downregulated by p53 but not by p63 or p73, Cell Cycle, 6, 853, 10.4161/cc.6.7.4017 · DOI
- Barsotti, 2009, Pro-proliferative FoxM1 is a target of p53-mediated repression, Oncogene, 28, 4295, 10.1038/onc.2009.282 · DOI · Paper page
- Gaub, 1990, Activation of the ovalbumin gene by the estrogen receptor involves the fos–jun complex, Cell, 63, 1267, 10.1016/0092-8674(90)90422-B · DOI · Paper page
- Dalvai, 2011, Cdc25B is negatively regulated by p53 through Sp1 and NF-Y transcription factors, Oncogene, 30, 2282, 10.1038/onc.2010.588 · DOI
- van der Watt, 2011, The nuclear exporter, Crm1, is regulated by NFY and Sp1 in cancer cells and repressed by p53 in response to DNA damage, Biochim. Biophys. Acta, 1809, 316, 10.1016/j.bbagrm.2011.05.017 · DOI
- Hirose, 2003, p53-independent induction of Gadd45 by histone deacetylase inhibitor: coordinate regulation by transcription factors Oct-1 and NF-Y, Oncogene, 22, 7762, 10.1038/sj.onc.1207091 · DOI
- Izumi, 2001, Mechanism for the transcriptional repression by c-Myc on PDGF beta-receptor, J. Cell Sci., 114, 1533, 10.1242/jcs.114.8.1533 · DOI · Paper page
- Mao, 2004, Promoter-binding and repression of PDGFRB by c-Myc are separable activities, Nucleic Acids Res., 32, 3462, 10.1093/nar/gkh669 · DOI
- Müller, 2010, The central role of CDE/CHR promoter elements in the regulation of cell cycle-dependent gene transcription, FEBS J., 277, 877, 10.1111/j.1742-4658.2009.07508.x · DOI · Paper page
- Jung, 2001, p53 and its homologues, p63 and p73, induce a replicative senescence through inactivation of NF-Y transcription factor, Oncogene, 20, 5818, 10.1038/sj.onc.1204748 · DOI
- Hackzell, 2002, p73 independent of c-Myc represses transcription of platelet-derived growth factor beta-receptor through interaction with NF-Y, J. Biol. Chem., 277, 39769, 10.1074/jbc.M204483200 · DOI
- Testoni, 2006, Mechanisms of transcriptional repression of cell-cycle G2/M promoters by p63, Nucleic Acids Res., 34, 928, 10.1093/nar/gkj477 · DOI
- Uramoto, 2004, p73 competes with co-activators and recruits histone deacetylase to NF-Y in the repression of PDGF beta-receptor, J. Cell Sci., 117, 5323, 10.1242/jcs.01384 · doi:10.1242/jcs.01384
- Liberati, 2001, Cooperation and competition between the binding of COUP-TFII and NF-Y on human epsilon- and gamma-globin gene promoters, J. Biol. Chem., 276, 41700, 10.1074/jbc.M102987200 · DOI
- Liberati, 1999, NF-Y binding to twin CCAAT boxes: role of Q-rich domains and histone fold helices, J. Mol. Biol., 285, 1441, 10.1006/jmbi.1998.2384 · doi:10.1006/jmbi.1998.2384
- Rinne, 2007, p63-associated disorders, Cell Cycle, 6, 262, 10.4161/cc.6.3.3796 · DOI · Paper page
- Melino, 2011, p63 is a suppressor of tumorigenesis and metastasis interacting with mutant p53, Cell Death Differ., 18, 1487, 10.1038/cdd.2011.81 · DOI · Paper page
- Benatti, 2008, A balance between NF-Y and p53 governs the pro- and anti-apoptotic transcriptional response, Nucleic Acids Res., 36, 1415, 10.1093/nar/gkm1046 · DOI · Paper page
- Gomes, 2010, Differential regulation of p53 target genes: it's (core promoter) elementary, Genes Dev., 24, 111, 10.1101/gad.1893610 · DOI
- Mantovani, 1992, Monoclonal antibodies to NF-Y define its function in MHC class II and albumin gene transcription, EMBO J., 11, 3315, 10.1002/j.1460-2075.1992.tb05410.x · DOI · Paper page
- Lecona, 2008, Upregulation of annexin A1 expression by butyrate in human colon adenocarcinoma cells: role of p53, NF-Y, and p38 mitogen-activated protein kinase, Mol. Cell. Biol., 28, 4665, 10.1128/MCB.00650-07 · DOI · Paper page
- Hughes, 2010, NF-Y is essential for expression of the proapoptotic bim gene in sympathetic neurons, Cell Death Differ., 18, 937, 10.1038/cdd.2010.166 · DOI
- Huang, 2010, Phospho-DeltaNp63alpha/NF-Y protein complex transcriptionally regulates DDIT3 expression in squamous cell carcinoma cells upon cisplatin exposure, Cell Cycle, 9, 328, 10.4161/cc.9.2.10432 · DOI
- Bhattacharya, 2003, The B subunit of the CCAAT box binding transcription factor complex (CBF/NF-Y) is essential for early mouse development and cell proliferation, Cancer Res., 63, 8167
- Benatti, 2011, Specific inhibition of NF-Y subunits triggers different cell proliferation defects, Nucleic Acids Res., 39, 5356, 10.1093/nar/gkr128 · DOI
- Hung, 2011, Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters, Nat. Genet., 43, 621, 10.1038/ng.848 · DOI · Paper page
- Gurtner, 2010, Transcription factor NF-Y induces apoptosis in cells expressing wild-type p53 through E2F1 upregulation and p53 activation, Cancer Res., 70, 9711, 10.1158/0008-5472.CAN-10-0721 · DOI
- Mahmoudi, 2009, Wrap53, a natural p53 antisense transcript required for p53 induction upon DNA damage, Mol. Cell, 33, 462, 10.1016/j.molcel.2009.01.028 · DOI · Paper page
- Mahmoudi, 2011, WRAP53 promotes cancer cell survival and is a potential target for cancer therapy, Cell Death Differ., 2, e114, 10.1038/cddis.2010.90 · DOI
- Ceribelli, 2009, NF-YC complexity is generated by dual promoters and alternative splicing, J. Biol. Chem., 284, 34189, 10.1074/jbc.M109.008417 · DOI
- Romano, 2006, Defining the regulatory elements in the proximal promoter of DeltaNp63 in keratinocytes: potential roles for Sp1/Sp3, NF-Y, and p63, J. Invest. Dermatol., 126, 1469, 10.1038/sj.jid.5700297 · DOI
- Hainaut, 1998, IARC Database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualisation tools, Nucleic Acids Res., 26, 205, 10.1093/nar/26.1.205 · DOI · Paper page
- Sigal, 2000, Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome, Cancer Res., 60, 6788
- Gurtner, 2010, Mutant p53-induced up-regulation of mitogen-activated protein kinase kinase 3 contributes to gain of function, J. Biol. Chem., 285, 14160, 10.1074/jbc.M109.094813 · DOI · Paper page
- Goodarzi, 2009, Revealing global regulatory perturbations across human cancers, Mol. Cell, 36, 900, 10.1016/j.molcel.2009.11.016 · DOI · Paper page
- Strano, 2002, Physical interaction with human tumor-derived p53 mutants inhibits p63 activities, J. Biol. Chem., 277, 18817, 10.1074/jbc.M201405200 · DOI · Paper page
- Liu, 2011, TopBP1 mediates mutant p53 gain of function through NF-Y and p63/p73, Mol Cell Biol., 22, 4464, 10.1128/MCB.05574-11 · DOI · Paper page
- Wright, 2006, TopBP1 contains a transcriptional activation domain suppressed by two adjacent BRCT domains, Biochem. J., 400, 573, 10.1042/BJ20060831 · DOI
Cited by
Census and evaluation of p53 target genes
Fischer, M. (2017) · Oncogene · doi:10.1038/onc.2016.502 · Cited by 971
Understanding the complexity of p53 in a new era of tumor suppression
Liu, Y., Su, Z., Tavana, O., & Gu, W. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.04.009 · Cited by 495
The transcription factor p53: Not a repressor, solely an activator.
Fischer, M., Steiner, L., & Engeland, K. (2014) · Cell Cycle · doi:10.4161/15384101.2014.949083 · Cited by 153
Quaas, M., Müller, G. A., & Engeland, K. (2012) · Cell Cycle · doi:10.4161/cc.22917 · Cited by 107
Metadata
- Authors
- Imbriano, C., Gnesutta, N., & Mantovani, R.
- Venue
- Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Publisher
- Elsevier BV
- Published
- 2012-04
- Volume
- 1825
- Issue
- 2
- Pages
- 131-139
- ISSN
- 0304-419X (ISSN-L)
- OpenAlex
- W2064715144
- Cited by
- 38
- References
- 18
- FWCI
- 2.07
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.